Monthly information related to total number of voting rights and shares composing the share capital – February 28, 2022
Erytech Pharma has disclosed its total share capital and voting rights as of January 31, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Erytech Pharma has disclosed its total share capital and voting rights as of January 31, 2022. The company reports a total of 31,018,553 shares, corresponding to 32,518,339 gross voting rights and 32,515,839 net voting rights. This data reflects the company’s compliance with Article 223-16 of the General Regulation of the French Autorité des Marchés Financiers. The reporting period is crucial for investors monitoring share structure changes and potential voting power shifts.
Positive
- Total shares as of January 31, 2022: 31,018,553
- Gross voting rights: 32,518,339
- Net voting rights: 32,515,839
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Article 223-16 of general regulation of French Autorité des Marchés Financiers
Lyon – France
Listing markets:
Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) &
Nasdaq Global Select Market in the United-States (Symbol : ERYP)
Website : www.erytech.com
| Date | Total of shares composing the share capital | Total of brut (1) voting rights | Total of net (2) voting rights |
| December 31, 2021 | 31 018 553 | 32 518 339 | 32 515 839 |
| January 31, 2022 | 31 018 553 | 32 518 339 | 32 515 839 |
| February 28, 2022 | 31 018 553 | 32 518 547 | 32 516 047 |
(1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2) Without treasury shares.
Attachment
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.